Fact CheckerSign in

NCT06845722Recruiting

Combined Effects of Balance and Cognitive Training in Patients With Multiple Sclerosis

Combined Effects of Balance and Cognitive Training on Executive Functions, Balance and Quality of Life in Patients With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 25 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Multiple sclerosis is a potentially disabling disease of the brain and spinal cord involving the central nervous system. Multiple Sclerosis can cause balance and cognitive impairment in patients, affecting overall quality of life. Balance and cognitive training can effectively improve the overall executive function and mobility in patients with multiple sclerosis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
42 (estimated)
First submitted
20 Feb 2025
Start date
1 Oct 2024
Primary completion date
20 Feb 2025
Lead sponsor
Riphah International University
NCT number
NCT06845722

What you commit to

  • Study type: Interventional
  • Planned participants: 42
  • From 1 Oct 2024 to the primary completion date, 20 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participants with a history of moderate to severe head injury, stroke and seizures will be excluded(23)
  • Cognitive impairment due to presence of current or past neurological disorders other than Multiple Sclerosis will be excluded.(23)
  • Participants with active major psychiatric illness (such as schizophrenia, bipolar disorder or depressive disorder) will be excluded(23)
  • Patients with history of learning disabilities, severe head trauma, alcohol or drug abuse will be excluded(23)

Who the study is looking for

  • Age of the patients should be 40-55 years.(20)
  • Gender: both males and females
  • Patients with diagnosed multiple sclerosis.
  • According to MOCA assessment, patients with scoring 21-25 will be included. (Patients with executive function deficits due to Multiple Sclerosis including relapsing-remitting, primary progressive and secondary progressive MS).(21)
  • Patients feel difficulty in Impaired Balance and walking.
  • According to the Berg Balance Scale, patients under 21-45 will be included.(22)

Age in the registry: 40 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jinnah Hospital
Coordinator of this site? Confirm its status
LahorePakistanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.